CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.

Laura AgrestaMaria LehnKristin LampeRachel CantrellCassandra HenniesSara SzaboTrisha Wise-DraperLaura ConfortiKasper HoebeEdith M Janssen

Published in: Journal for immunotherapy of cancer (2020)

Together these data suggest that CD244 contributes to the overall immune-suppressive environment and therefore has potential as a new immunotherapy target in the treatment of malignancies.

Keyphrases

nk cells
electronic health record
big data
data analysis